Gerontology & Obesity Flashcards
Decreased Propofol requirements for general anesthesia in the elderly
Propofol dose 15% lower in elderly vs young adults
MAC decrease per decade
6%
Cardiovascular changes in the elderly
HTN: loss of vascular elasticity
Difficulty increasing cardiac output: Reduced efficacy of beta agonists, endogenous physiological beta blocker, diminished baroreceptor responses
Prolonged circulation time
*Accelerates induction of inhalation agents but decreases onset for IV induction
*Baroreceptor responses respond to vascular tone (increase/decrease HR/BP)
Pulmonary changes in the elderly
Elastin isn’t replaced by collagen
Ideal body weight
AKA Broca’s index
-Lowest morbidity and mortality for a given population
= height (cm) - men(100) or women(105)
Converting inches to centimeters
In x 2.54 = cm
Lean body weight
TBW - adipose tissue
=IBW x 1.3
-Doesn’t work for nonobese people (TBW=IBW)
BMI cutoff for obesity and overweight
> 30 obese
>25 overweight (often inaccurate for muscular individuals)
CV system and obesity (and EBV calculation for obese)
CO increases 0.1L/min for every kg fat gain (d/t increased O2 consumption)
-HR constant, achieved by increased SV
-Greater demand on myocardium -> LV hypertrophy
-Increased total blood volume
EBV=45-50mL/kg (instead of 70)
Obese non-hypertensive heart adaptation to obesity/HTN
Decrease SVR
Increased blood volume -> eccentric dilated heart
Obese and uncontrolled HTN heart adaptation to obesity/HTN
Increased blood volume
Mixed eccentric/dilated and concentric/ventricular hypertrophy (wall thickening)
-Will lead to heart failure and pulmonary hypertension
*Wall thickening plus increased blood volume
Obesity increased risk of hypercoagulability
Increased clotting factors -Fibrinogen -Factor VII -Factor VIII -vWF -Plasminogen activator factor Predisposes to fibrin clot formation 3x risk of developing CAD for every unit change in BMI -Obese 50% increased risk of DVT vs nonobese
Thromboembolic disorders in obese patients
Increased risk of CVA or PE
-Related to prothrombotic and chronic inflammatory state because of excess adipose tissue accumulation
O2/CO2 changes in obese
Increased O2 consumption and CO2 production
-Maintain normocapnia by increasing MV (rapid shallow breathing) - uses the least amount of energy
Obesity effect on ERV
Expiratory reserve volume
- Decreased
- Most sensitive indicator of pulmonary function in obese individuals
OSA/Hypopnea syndrome in obese patients
Apnea -Reduction in airflow >10 seconds ->15 episodes/hr of sleep -Decreased SaO2 >4% Test -OPS: Overnight polysomnography -Inconvenient, a majority of patients are undiagnosed
3 types of sleep apnea
OSA
-Periodic/partial/complete obstruction
-Respiratory efforts but no airflow, produced by excess soft tissue
Central sleep apnea
-No respiratory efforts
Mixed
-Attributes of both OSA/central sleep apnea
-Delayed effort with varying degrees of obstruction
*All associated with decreased O2 levels
STOP Bang
Screening tool for OSA -Sensitivity of 93% Snoring Tiredness Observed stop breathing Blood Pressure BMI>35 Age>50 Neck circumference>40cm Gender male High risk = 3+ items -Refer for sleep testing
Nonalcoholic fatty liver disease (NAFLD)
Increased adipose tissue -> increased intrahepatic triglycerides, impaired insulin activity, release of inflammatory cytokines
-Destruction of hepatocytes and cirrhosis
-Elevated ALT
-Benign form of hepatitis but can lead to HCC, portal HTN
Mortality from liver disease is 1.5-2.5 higher than nonobese
Endocrine/Metabolic disease and obesity
Pancreas: infiltrated with fat -> decreased insulin secretion
Adipocytes: enlarged -> insulin resistance
Abnormal glucose tolerance, hyperglycemia, insulin resistance -> increased wound infection, silent MI
Surgical stress -> adrenal release cortisol -> increased need for insulin
Subclinical hypothyroidism in 25% morbidly obese -> increased TSH levels and possibly TH resistance in tissues
Too small of a BP cuff ___estimates the BP
Overestimates
Pharmacology for obese patients
Water soluble meds based on IBW
Lipid soluble meds based on TBW
Lipophillic drugs have increased volume of distribution (elimination half life is prolonged)
-Benzos and barbiturates : Don’t redose!
Muscle relaxant dosing in obese
Nondepolarizing: Based on IBW (or even lean body weight)
Succinylcholine: Based on TBW (pseudocholinesterase activity is increased in obesity)
Opioid use in obesity
Initial dose is the same but repeat doses are less predictable